Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Titel:
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Auteur:
Weller, Michael Butowski, Nicholas Tran, David D Recht, Lawrence D Lim, Michael Hirte, Hal Ashby, Lynn Mechtler, Laszlo Goldlust, Samuel A Iwamoto, Fabio Drappatz, Jan O'Rourke, Donald M Wong, Mark Hamilton, Mark G Finocchiaro, Gaetano Perry, James Wick, Wolfgang Green, Jennifer He, Yi Turner, Christopher D Yellin, Michael J Keler, Tibor Davis, Thomas A Stupp, Roger Sampson, John H